Why is Torrent Pharma falling/rising?

As of 16-Sep, Torrent Pharmaceuticals Ltd. has a current price of 3,534.55, reflecting a slight increase of 3.5 (0.1%). The stock has shown a trend reversal, gaining after four consecutive days of decline, although it has traded within a narrow range of Rs 29.95. Despite this recent uptick, the stock has underperformed in the short term, with a 1-week return of -2.74% and a 1-month return of -2.42%. However, it has demonstrated strong performance over the longer term, with a year-to-date return of +5.33% and a remarkable +139.25% return over the past three years. The company's high management efficiency, evidenced by a robust ROCE of 22.33% and a low Debt to EBITDA ratio of 1.26 times, supports its ability to service debt and maintain positive results over the last eight quarters, which may contribute to investor confidence.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has gained +1.58% over the past week and +2.21% over the past month. This indicates that while Torrent Pharmaceuticals has faced short-term challenges, the overall market has been performing well. The decline in delivery volume by -28.52% against the 5-day average suggests falling investor participation, which could be a concern for future price movements. Nonetheless, the stock's high institutional holdings at 24.75% indicate that knowledgeable investors are backing the company, which may provide some stability despite the recent fluctuations.